Αποτελέσματα Αναζήτησης
3 Ιουλ 2023 · Intravenous immunoglobulin (IVIG) is a pooled antibody, and a biological agent used to manage various immunodeficiency states and a plethora of other conditions, including autoimmune, infectious, and inflammatory states. The ultimate goal of this therapy is to normalize a compromised immune system.
Immunoglobulin (Ig) replacement therapy is the standard treatment for individuals with antibody deficiencies. Ig is given intravenously (IVIG) or subcutaneously (SCIG) and replaces the antibodies a person should be making.
Immunoglobulin replacement therapy is the standard-of-care treatment for patients with primary immunodeficiency diseases who have impaired antibody production and function. Clinicians and patients may consider intravenous immunoglobulin (IVIG) or ...
21 Μαΐ 2024 · Intravenous Immunoglobulin (IVIG) therapy is a biologic treatment used for immunodeficiencies, medical conditions that compromise the immune system. Learn more about how it works and what to expect when receiving it.
23 Φεβ 2016 · This topic will review the uses, proposed mechanisms of action, and administration of intravenous immune globulin (IVIG). Additional topic reviews discuss the adverse effects of IVIG therapy and the administration of immune globulin by subcutaneous and intramuscular routes.
30 Ιουλ 2024 · One reason you might need IVIG is if your body does not make enough antibodies. This is called "humoral immunodeficiency"; it may be primary (something you are born with) or secondary (caused by another condition). The IVIG simply provides extra antibodies that your body cannot make on its own.
Dose - IVIG is indicated for patients with primary immunodeficiency at a starting dose of 400-600 mg/kg every 3-4 weeks. Less frequent treatment, or use of lower doses, is not substantiated by clinical data.
